Are you serious? Are you talking about the same company? Last quarter, CJES reported negative 29 million cash flows from operating activities and negative 31 million of adjusted ebitda. If that is not a cash flow problem, I don't know what is.
They are hemorrhaging cash. That is why the restructuring agreement includes 400 million of new financing.
It is difficult to say how they are doing compared to SUNE, because SUNE has not reported their results for many quarters, but they are doing very badly and I do not see how equity gets anything.